BsAb Analysis
Bispecific antibodies have reached outstanding clinical results. To develop BsAbs for treating diseases, it is critically important to perform comprehensive analysis for BsAbs to ensure their quality and function. Quality assessment, characteristic analysis, as well as preclinical research are necessary during the different stages of BsAb development.


Home > BsAb Analysis
Bispecific Antibody Analysis
Biochemical characterization plays an important role in the BsAb development. We offer a variety of biochemical characterization services for your BsAbs, including purity measurement, molecular weight/mass measurement, as well as molecular structure analysis.
Learn More
Our stability analysis is mainly composed of three parts: aggregation measurement, thermal stability measurement, and in vitro serum stability measurement. Protein aggregation has crucial effects on drug potency and results in highly undesirable immune effects. Therefore, it is very important to measure aggregation conditions for therapeutic antibodies.
Learn More
Bispecific Antibody Analysis
Bispecific Antibody Analysis
We offer a number of functional analysis services for BsAbs, such as target binding affinity measurement, ADCC assay, CDC assay, and ADCP assay. In addition, we have developed a reporter-gene assay that enables fast and more reliable measurement of ADCP for BsAbs.
Learn More
Usually, antibody drugs display much more complex PK/PD properties than those common small-molecule drugs. For the development of therapeutic antibodies, absorption analysis, distribution analysis, metabolism and elimination analysis are all available in Creative Biolabs.
Learn More
Bispecific Antibody Analysis
Bispecific Antibody Analysis
In order to measure the efficacy and safety of the drug candidates during drug development, a range of models, ranging from test tube experiments to cell cultures, animals, and healthy human subjects, are utilized at different stages. Creative Biolabs has established various models for your BsAb development.
Learn More
Focus on Bispecific Antibody, Focus on Creative Biolabs

Novel Platforms Facilitate Innovative and Efficient BsAb Development